Skip to main content
. 2015 Mar 20;5:14. doi: 10.1186/s13550-015-0088-0

Figure 4.

Figure 4

Whole brain TACs of [ 11 C]erlotinib (left) and [ 18 F]afatinib (right) before and after tariquidar pre-treatment. TACs are averaged over three animals.